Hepatitis A Synthetic Peptide VP3(110–121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers
✍ Scribed by P. Sospedra; M.A. Alsina; M. Espina; F. Reig; I. Haro; C. Mestres
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 82 KB
- Volume
- 221
- Category
- Article
- ISSN
- 0021-9797
No coin nor oath required. For personal study only.
✦ Synopsis
To prepare liposomes containing a synthetic hepatitis A virus antigen (HAV) [VP3(110-121)] as a vaccine, the miscibility of this peptide (with negative net charge) with a neutral lipid [dipalmitoylphosphatidylcholine (DPPC)], a negatively charged lipid [dipalmitoylphosphatidylglycerol (DPPG)], and a positively charged lipid [Stearylamine (SA)] was studied through compression isotherms of monolayers. Mixtures with DPPC and SA showed a low degree of interaction with the peptide, the composition of the monolayer being stable through compression. For DPPGcontaining monolayers larger positive deviations from ideality were found, and the peptide was squeezed out from the monolayer at a DPPG/VP3(110-121) mole fraction of 0.8/0.2. All this suggests that besides hydrophobic interactions between the peptide and the lipid, electrostatic forces also play a role; thus it seems that neutral and positively charged lipids would be more suitable for preparing stable liposomes with VP3(110-121).
📜 SIMILAR VOLUMES
In the present work the pattern of miscibility between a hepatitis A virus (HAV) synthetic peptide (AcVP3110) with monolayers composed of lipids of different charge was studied. Zwitterionic (dipalmitoyl phosphatidylcholine (DPPC)), anionic (dipamitoyl phosphatidylglycerol (DPPG)), and cationic (ste
Synthetic peptide vaccines are safer and cheaper than classical ones, but immunoresponse is usually lower. The early interaction of hepatitis A virus (HAV) with cells during the infection and immunological response processes is not as well-known as for other picornavirus. However, it seems that elec